Sussan Nourshargh | |
|---|---|
| Education | University College London |
| Occupation | Professor of Microvascular Pharmacology |
Sussan Nourshargh is a British immunologist, pharmacologist, and professor of microvascular pharmacology and immunopharmacology. She founded the Centre for Microvascular research at Queen Mary University.
Sussan Nourshargh studied pharmacology (BSc) at University College London and did her PhD at King's College London. [1]
Nourshargh held a post-doctoral research scientist post in vascular biology at MRC Clinical Sciences Centre, [2] London between 1986-1988. In 1988 she became a senior lecturer within the department of Applied Pharmacology at the National Heart and Lung Institute, [3] part of Imperial College London.
In 2006 Nourshargh became a professor of immunopharmacology at Imperial College London, a year later she founded the Centre for Microvascular Research [4] within the William Harvey Research Institute [5] at Queen Mary University.
 | This section of a biography of a living person does not include any references or sources .(June 2020) |
Sir Henry Hallett Dale was an English pharmacologist and physiologist. For his study of acetylcholine as agent in the chemical transmission of nerve pulses (neurotransmission) he shared the 1936 Nobel Prize in Physiology or Medicine with Otto Loewi.
A fellow is a concept whose exact meaning depends on context. In learned or professional societies, it refers to a privileged member who is specially elected in recognition of their work and achievements. Within the context of higher educational institutions, a fellow can be a member of a highly ranked group of teachers at a particular college or university or a member of the governing body in some universities; it can also be a specially selected postgraduate student who has been appointed to a post granting a stipend, research facilities and other privileges for a fixed period in order to undertake some advanced study or research, often in return for teaching services. In the context of research and development-intensive large companies or corporations, the title "fellow" is sometimes given to a small number of senior scientists and engineers. In the context of medical education in North America, a fellow is a physician who is undergoing a supervised, sub-specialty medical training (fellowship) after having completed a specialty training program (residency).
Barts and The London School of Medicine and Dentistry, commonly known as Barts or BL, is a medical and dental school in London, England. The school is part of Queen Mary University of London, a constituent college of the federal University of London, and the United Hospitals. It was formed in 1995 by the merger of the London Hospital Medical College and the Medical College of St Bartholomew's Hospital.
Sir John Robert Vane was a British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors. He was awarded the Nobel Prize in Physiology or Medicine in 1982 along with Sune Bergström and Bengt Samuelsson for "their discoveries concerning prostaglandins and related biologically active substances".
Dame Bridget Margaret Ogilvie, is an Australian and British scientist.
Anne Cooke, is a British biologist and academic, specialising in immunology and autoimmune diseases. From 2000 to 2013, she was Professor of Immunobiology at the University of Cambridge. She was a fellow of King's College, Cambridge, between 1992 and 2013.
Frances Rosemary Balkwill is an English scientist, Professor of Cancer Biology at Queen Mary University of London, and author of children's books about scientific topics.
Donald Robert James Singer was a British clinical pharmacologist who was the president of the Fellowship of Postgraduate Medicine.
Stuart Graham Cull-Candy is a British neuroscientist. He holds the Gaddum Chair of Pharmacology and a personal Chair in Neuroscience at University College London. He is also a member of the Faculty of 1000 and held a Royal Society - Wolfson Research position.
Roderick John Flower, also known as Rod, is a British pharmacologist, and professor at Barts and The London School of Medicine and Dentistry. Dr. Flower is a member of the board of directors of Antibe Therapeutics and on the scientific advisory board of Morria.
Elizabeth Matilda Tansey is an Emerita Professor of the history of medicine and former neurochemist, best known for her role in the Wellcome Trust's witness seminars. She previously worked at Queen Mary University of London (QMUL).
Doreen Ann CantrellCBE, FRS, FRSE, FMedSci is an English scientist and Professor of Cellular Immunology at the School of Life Sciences, University of Dundee. She researches the development and activation T lymphocytes, which are key to the understanding the immune response.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
Professor Sir Munir Pirmohamed is a British clinical pharmacologist and geneticist. Since 2007 he has been the NHS Chair of Pharmacogenetics at the University of Liverpool.
The History of Modern Biomedicine Research Group (HoMBRG) is an academic organisation specialising in recording and publishing the oral history of twentieth and twenty-first century biomedicine. It was established in 1990 as the Wellcome Trust's History of Twentieth Century Medicine Group, and reconstituted in October 2010 as part of the School of History at Queen Mary University of London.
Shoumo Bhattacharya is an Indian medical doctor and academic, and the British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the BHF Centre of Research Excellence, University of Oxford.
Clare Margaret Lloyd is a Professor of Medicine and Vice Dean for Institutional Affairs at Imperial College London. She investigates allergic immunity in early life.
Sir Mark Jonathan Caulfield MD, FRCP, FESC, FPharm, FBHS, FMedSci (born 19 July 1960) is a British genomic medicine researcher and Warden of Barts and The London School of Medicine and Dentistry. He is the Professor of Clinical Pharmacology at the William Harvey Research Institute in Queen Mary University of London. He was awarded a knighthood in the 2019 Birthday Honours.
Karim Hassan Brohi is a British surgeon who is currently the clinical director of the London Major Trauma Network, Professor of Trauma Sciences at Queen Mary University of London and a Consultant vascular and trauma surgeon for Barts Health NHS Trust at the Royal London Hospital.
Kevin Marsh is a British Malariologist, academic and a researcher. He is a professor of Tropical Medicine and Director of Africa Oxford Initiative at University of Oxford. He is also a senior advisor at African Academy of Sciences.
| International | |
|---|---|
| National | |
| Other | |
